Clinical Trials and Research News Weekly Roundup | Dr. Tarek Alam’s Ivermectin Working |S2 E30

TrialSite News Weekly Roundup

Bangladesh Medical College’s Dr. Tarek Alam’s Ivermectin Working 98% With Between 400-500 Patients & More Research to Come: Dr. Tarek Alam, a highly respected physician and professor of Medicine at Bangladesh Medical College (BMC), used two economical and easily available drugs to treat patients suffering from COVID-19 with considerable success in not only reducing the patients’ viral load, but also cutting the severity of their cases. Dr. Alam, who kindly did an interview with TrialSite News, reports that 98% of his COVID-19 patients are cured by the combined use of anti-parasitic drug ivermectin and antibiotic Doxycycline within 4 to 14 days. As Dr. Alam reported to the TrialSite, he secured BMC approved protocol to use this combination to great success.
Degrees Pharmaceuticals & Collaborative Team Declare Antiparasitic Tafenoquine Zaps Sars-Cov-2 in a Cell Culture:A small Washington, D.C.-based biotech firm called Sixty Degrees Pharmaceuticals (60P) in partnership with commercial labs, a drug development services company, and the Gates Foundation recently conducted a series of laboratory...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee